Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zfp691
|
ENSMUSG00000045268.7 | zinc finger protein 691 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_119178414_119178597 | Zfp691 | 4310 | 0.103826 | -0.59 | 1.8e-06 | Click! |
chr4_119177916_119178067 | Zfp691 | 3796 | 0.109362 | -0.59 | 2.5e-06 | Click! |
chr4_119174076_119174386 | Zfp691 | 36 | 0.947475 | -0.46 | 4.2e-04 | Click! |
chr4_119173652_119174022 | Zfp691 | 19 | 0.949482 | -0.31 | 2.2e-02 | Click! |
chr4_119158070_119158348 | Zfp691 | 15647 | 0.083481 | -0.19 | 1.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_3067329_3068553 | 86.22 |
Gm27878 |
predicted gene, 27878 |
16122 |
0.2 |
chr4_3082761_3083956 | 78.99 |
Vmn1r-ps2 |
vomeronasal 1 receptor, pseudogene 2 |
21234 |
0.18 |
chr4_3051990_3053232 | 76.72 |
Gm27878 |
predicted gene, 27878 |
792 |
0.7 |
chr16_3236385_3237472 | 67.76 |
Gm23215 |
predicted gene, 23215 |
12656 |
0.18 |
chr16_3238621_3239720 | 67.03 |
Gm23215 |
predicted gene, 23215 |
10414 |
0.18 |
chr16_3233110_3233980 | 46.49 |
Gm23215 |
predicted gene, 23215 |
16039 |
0.17 |
chr4_3084084_3084549 | 29.89 |
Vmn1r-ps2 |
vomeronasal 1 receptor, pseudogene 2 |
20276 |
0.18 |
chr16_3235917_3236318 | 22.94 |
Gm23215 |
predicted gene, 23215 |
13467 |
0.17 |
chr16_3235018_3235638 | 18.61 |
Gm23215 |
predicted gene, 23215 |
14256 |
0.17 |
chr4_3085361_3086079 | 12.88 |
Vmn1r-ps2 |
vomeronasal 1 receptor, pseudogene 2 |
18872 |
0.18 |
chr16_16561093_16561486 | 10.22 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
1070 |
0.53 |
chr7_44861995_44862146 | 9.94 |
Pnkp |
polynucleotide kinase 3'- phosphatase |
373 |
0.63 |
chr9_8900765_8902148 | 9.94 |
Pgr |
progesterone receptor |
988 |
0.68 |
chr1_6751179_6751330 | 9.27 |
St18 |
suppression of tumorigenicity 18 |
13679 |
0.26 |
chr19_58113422_58113599 | 8.91 |
Gm50287 |
predicted gene, 50287 |
17479 |
0.24 |
chr19_36377812_36378102 | 8.74 |
Pcgf5 |
polycomb group ring finger 5 |
1111 |
0.41 |
chr4_3059983_3060374 | 8.61 |
Gm27878 |
predicted gene, 27878 |
8359 |
0.23 |
chr4_3084961_3085283 | 8.48 |
Vmn1r-ps2 |
vomeronasal 1 receptor, pseudogene 2 |
19470 |
0.18 |
chr4_3060914_3061262 | 8.37 |
Gm27878 |
predicted gene, 27878 |
9269 |
0.23 |
chr4_3064291_3064619 | 8.15 |
Gm27878 |
predicted gene, 27878 |
12636 |
0.21 |
chr16_3234456_3234976 | 8.10 |
Gm23215 |
predicted gene, 23215 |
14868 |
0.17 |
chr4_72382561_72382773 | 8.09 |
Gm11235 |
predicted gene 11235 |
159999 |
0.04 |
chr14_59736746_59737101 | 8.02 |
Gm19716 |
predicted gene, 19716 |
94375 |
0.07 |
chr4_3081573_3082012 | 7.80 |
Vmn1r-ps2 |
vomeronasal 1 receptor, pseudogene 2 |
22800 |
0.17 |
chr10_34206475_34207143 | 7.63 |
Dse |
dermatan sulfate epimerase |
268 |
0.86 |
chr4_3080817_3081088 | 7.35 |
Vmn1r-ps2 |
vomeronasal 1 receptor, pseudogene 2 |
23640 |
0.17 |
chr10_36507139_36507637 | 7.26 |
Hs3st5 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 5 |
19 |
0.99 |
chr1_135563875_135564411 | 7.22 |
Gm4793 |
predicted gene 4793 |
20630 |
0.15 |
chr14_12189722_12190070 | 7.02 |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
47 |
0.98 |
chr16_3232679_3233066 | 6.98 |
Gm23215 |
predicted gene, 23215 |
16712 |
0.17 |
chr15_37175261_37175424 | 6.93 |
Gm9509 |
predicted gene 9509 |
2938 |
0.23 |
chr4_48581411_48581592 | 6.92 |
Tmeff1 |
transmembrane protein with EGF-like and two follistatin-like domains 1 |
3673 |
0.25 |
chr14_79773765_79773944 | 6.82 |
Pcdh8 |
protocadherin 8 |
2542 |
0.22 |
chr4_3062563_3062995 | 6.76 |
Gm27878 |
predicted gene, 27878 |
10960 |
0.22 |
chr13_68581487_68582271 | 6.57 |
Mtrr |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
15 |
0.85 |
chr5_77207847_77208140 | 6.50 |
Spink2 |
serine peptidase inhibitor, Kazal type 2 |
3212 |
0.19 |
chr3_9173889_9174631 | 6.48 |
Zbtb10 |
zinc finger and BTB domain containing 10 |
76342 |
0.09 |
chr1_55705296_55705467 | 6.43 |
Plcl1 |
phospholipase C-like 1 |
3356 |
0.36 |
chr1_172049306_172049831 | 6.41 |
Nhlh1 |
nescient helix loop helix 1 |
8005 |
0.11 |
chr7_64840957_64841275 | 6.37 |
Fam189a1 |
family with sequence similarity 189, member A1 |
15281 |
0.22 |
chr11_6603325_6604219 | 6.28 |
Nacad |
NAC alpha domain containing |
2281 |
0.14 |
chr2_45225367_45225747 | 6.28 |
Gm28643 |
predicted gene 28643 |
68632 |
0.11 |
chr7_62348079_62348404 | 6.23 |
Ndn |
necdin |
1672 |
0.38 |
chr13_28416864_28417183 | 6.13 |
Gm40841 |
predicted gene, 40841 |
2840 |
0.33 |
chr9_10269473_10269801 | 6.10 |
Gm24496 |
predicted gene, 24496 |
20950 |
0.22 |
chr7_79536474_79536625 | 6.09 |
Gm35040 |
predicted gene, 35040 |
506 |
0.62 |
chr2_38425074_38425256 | 6.00 |
Gm13589 |
predicted gene 13589 |
1163 |
0.43 |
chr13_34133930_34134147 | 5.94 |
Gm36500 |
predicted gene, 36500 |
178 |
0.9 |
chr8_34891056_34891249 | 5.85 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
1001 |
0.61 |
chr6_50536486_50536914 | 5.83 |
Gm26289 |
predicted gene, 26289 |
3334 |
0.17 |
chr12_29789065_29789261 | 5.81 |
Myt1l |
myelin transcription factor 1-like |
51047 |
0.17 |
chr3_86919762_86920123 | 5.78 |
Dclk2 |
doublecortin-like kinase 2 |
228 |
0.91 |
chr3_88230737_88231417 | 5.77 |
Gm3764 |
predicted gene 3764 |
2294 |
0.13 |
chr13_34129793_34130880 | 5.74 |
Tubb2b |
tubulin, beta 2B class IIB |
18 |
0.96 |
chr4_3059694_3059936 | 5.74 |
Gm27878 |
predicted gene, 27878 |
7996 |
0.23 |
chr18_25678986_25679896 | 5.73 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
34329 |
0.19 |
chr9_119510823_119511314 | 5.73 |
Scn5a |
sodium channel, voltage-gated, type V, alpha |
51610 |
0.1 |
chr2_109960340_109960539 | 5.70 |
Lgr4 |
leucine-rich repeat-containing G protein-coupled receptor 4 |
15103 |
0.19 |
chr10_13982761_13983386 | 5.53 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
16049 |
0.19 |
chr13_57930525_57930676 | 5.46 |
Spock1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1 |
22268 |
0.23 |
chr4_82592736_82592936 | 5.45 |
Gm11267 |
predicted gene 11267 |
5517 |
0.24 |
chr1_14506457_14507042 | 5.43 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
196514 |
0.03 |
chr10_109010922_109011131 | 5.38 |
Syt1 |
synaptotagmin I |
44 |
0.99 |
chr15_25760747_25760954 | 5.37 |
Myo10 |
myosin X |
2065 |
0.38 |
chr4_3082080_3082457 | 5.37 |
Vmn1r-ps2 |
vomeronasal 1 receptor, pseudogene 2 |
22324 |
0.17 |
chr7_46556876_46557027 | 5.37 |
Gm15700 |
predicted gene 15700 |
4350 |
0.16 |
chr10_49784952_49785123 | 5.34 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
1628 |
0.32 |
chr3_33142428_33143483 | 5.33 |
Pex5l |
peroxisomal biogenesis factor 5-like |
121 |
0.97 |
chr13_20609411_20609562 | 5.32 |
Gm47721 |
predicted gene, 47721 |
36271 |
0.17 |
chr4_21932308_21932628 | 5.32 |
Faxc |
failed axon connections homolog |
1111 |
0.54 |
chr15_30383087_30383401 | 5.29 |
Gm49283 |
predicted gene, 49283 |
45600 |
0.17 |
chr16_14265466_14265813 | 5.28 |
Myh11 |
myosin, heavy polypeptide 11, smooth muscle |
25724 |
0.14 |
chr4_3050363_3050695 | 5.27 |
Gm27878 |
predicted gene, 27878 |
1290 |
0.53 |
chr3_55424227_55424378 | 5.27 |
Gm42609 |
predicted gene 42609 |
21180 |
0.15 |
chr5_38157528_38157972 | 5.26 |
Nsg1 |
neuron specific gene family member 1 |
1281 |
0.39 |
chr8_95001110_95002377 | 5.26 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
862 |
0.47 |
chr1_119457535_119457729 | 5.24 |
Ralb |
v-ral simian leukemia viral oncogene B |
20447 |
0.14 |
chr1_194721621_194721772 | 5.19 |
2900035J10Rik |
RIKEN cDNA 2900035J10 gene |
11011 |
0.17 |
chr7_44861803_44861971 | 5.18 |
Pnkp |
polynucleotide kinase 3'- phosphatase |
190 |
0.83 |
chr14_68123095_68123255 | 5.17 |
Nefm |
neurofilament, medium polypeptide |
1671 |
0.34 |
chr8_61516539_61516725 | 5.16 |
Palld |
palladin, cytoskeletal associated protein |
732 |
0.72 |
chr6_53015147_53015337 | 5.15 |
Gm26215 |
predicted gene, 26215 |
4710 |
0.24 |
chr18_21186237_21186430 | 5.13 |
Gm6378 |
predicted pseudogene 6378 |
109224 |
0.05 |
chr8_4206127_4207837 | 5.11 |
4932443L11Rik |
RIKEN cDNA 4932443L11 gene |
100 |
0.88 |
chrX_159414805_159414993 | 5.10 |
Map7d2 |
MAP7 domain containing 2 |
327 |
0.87 |
chr19_22138901_22139141 | 5.09 |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
25 |
0.99 |
chr2_76498827_76499126 | 5.09 |
Osbpl6 |
oxysterol binding protein-like 6 |
121 |
0.97 |
chr7_63445460_63445631 | 5.08 |
Otud7a |
OTU domain containing 7A |
768 |
0.51 |
chr8_87836611_87837241 | 5.08 |
Zfp423 |
zinc finger protein 423 |
32487 |
0.22 |
chr3_154125282_154125505 | 5.07 |
Gm3076 |
predicted gene 3076 |
6947 |
0.2 |
chr2_151970289_151970825 | 5.04 |
Fam110a |
family with sequence similarity 110, member A |
2837 |
0.17 |
chr8_70476397_70477967 | 5.04 |
Klhl26 |
kelch-like 26 |
214 |
0.86 |
chr13_107663727_107663878 | 5.04 |
1700006H21Rik |
RIKEN cDNA 1700006H21 gene |
23595 |
0.19 |
chr8_50708330_50708481 | 4.98 |
Gm23986 |
predicted gene, 23986 |
145164 |
0.04 |
chr1_41742721_41742927 | 4.98 |
Gm29260 |
predicted gene 29260 |
38984 |
0.22 |
chr15_25763044_25763475 | 4.96 |
Myo10 |
myosin X |
4474 |
0.26 |
chr6_141568677_141568868 | 4.95 |
Slco1c1 |
solute carrier organic anion transporter family, member 1c1 |
22608 |
0.23 |
chr16_31500049_31500215 | 4.94 |
Gm46560 |
predicted gene, 46560 |
8255 |
0.16 |
chrX_146962369_146962534 | 4.90 |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C |
62 |
0.96 |
chr11_80602962_80603175 | 4.89 |
C030013C21Rik |
RIKEN cDNA C030013C21 gene |
93962 |
0.07 |
chr4_130866211_130866362 | 4.87 |
Gm22660 |
predicted gene, 22660 |
8406 |
0.15 |
chr2_11060169_11060355 | 4.86 |
Gm13264 |
predicted gene 13264 |
23389 |
0.1 |
chr7_95688461_95688640 | 4.85 |
Gm44603 |
predicted gene 44603 |
213604 |
0.02 |
chr6_6869149_6869300 | 4.84 |
Dlx6os1 |
distal-less homeobox 6, opposite strand 1 |
2368 |
0.19 |
chr3_130961832_130962002 | 4.79 |
2010110G14Rik |
RIKEN cDNA 2010110G14 gene |
24580 |
0.12 |
chr15_37175467_37175618 | 4.76 |
Gm9509 |
predicted gene 9509 |
3138 |
0.22 |
chr16_9994079_9994581 | 4.76 |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
60 |
0.98 |
chr10_109684428_109684622 | 4.74 |
3110043J17Rik |
RIKEN cDNA 3110043J17 gene |
35746 |
0.19 |
chr2_25500046_25500503 | 4.73 |
C8g |
complement component 8, gamma polypeptide |
19 |
0.86 |
chr2_51753056_51753280 | 4.73 |
Gm13490 |
predicted gene 13490 |
21159 |
0.21 |
chr12_3371975_3372463 | 4.72 |
Gm48511 |
predicted gene, 48511 |
3790 |
0.15 |
chr14_114587761_114587969 | 4.67 |
Gm37495 |
predicted gene, 37495 |
233360 |
0.02 |
chr19_41743543_41743739 | 4.67 |
Slit1 |
slit guidance ligand 1 |
24 |
0.98 |
chr14_24841640_24841791 | 4.64 |
Gm47906 |
predicted gene, 47906 |
8080 |
0.26 |
chr4_57638055_57638394 | 4.63 |
Pakap |
paralemmin A kinase anchor protein |
249 |
0.95 |
chr13_97437048_97437199 | 4.62 |
Lncenc1 |
long non-coding RNA, embryonic stem cells expressed 1 |
2153 |
0.29 |
chr12_79782713_79783051 | 4.59 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
141851 |
0.04 |
chr2_30646949_30647338 | 4.59 |
9330198N18Rik |
RIKEN cDNA 9330198N18 gene |
17488 |
0.14 |
chr10_11960614_11960850 | 4.59 |
Gm25011 |
predicted gene, 25011 |
852 |
0.62 |
chr19_33366744_33366922 | 4.57 |
Rnls |
renalase, FAD-dependent amine oxidase |
25432 |
0.18 |
chr2_6594259_6594464 | 4.57 |
Celf2 |
CUGBP, Elav-like family member 2 |
1561 |
0.51 |
chr1_176274614_176274863 | 4.52 |
Pld5 |
phospholipase D family, member 5 |
536 |
0.71 |
chr10_51826698_51826849 | 4.51 |
Gm47614 |
predicted gene, 47614 |
39832 |
0.13 |
chr16_3238346_3238611 | 4.51 |
Gm23215 |
predicted gene, 23215 |
11106 |
0.18 |
chr2_172731535_172731697 | 4.50 |
Gm22773 |
predicted gene, 22773 |
132725 |
0.04 |
chr4_33526336_33526610 | 4.50 |
Gm11935 |
predicted gene 11935 |
73584 |
0.1 |
chr7_93062767_93062929 | 4.47 |
Fam181b |
family with sequence similarity 181, member B |
17017 |
0.16 |
chr8_57836586_57836749 | 4.46 |
Galntl6 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 |
6391 |
0.24 |
chr19_21054279_21054445 | 4.46 |
4930554I06Rik |
RIKEN cDNA 4930554I06 gene |
50140 |
0.15 |
chr10_126028707_126028858 | 4.44 |
Gm22183 |
predicted gene, 22183 |
8045 |
0.25 |
chr12_112241365_112241542 | 4.43 |
Gm20368 |
predicted gene, 20368 |
36300 |
0.14 |
chr15_42304154_42304305 | 4.42 |
Gm49452 |
predicted gene, 49452 |
16117 |
0.18 |
chr3_50044774_50044968 | 4.42 |
Gm37826 |
predicted gene, 37826 |
15202 |
0.23 |
chr8_66910761_66911024 | 4.42 |
Gm39185 |
predicted gene, 39185 |
4895 |
0.21 |
chrX_52348896_52349142 | 4.42 |
Mir6384 |
microRNA 6384 |
29162 |
0.19 |
chr5_103336083_103336307 | 4.41 |
Gm42619 |
predicted gene 42619 |
7777 |
0.16 |
chr3_55353905_55354441 | 4.40 |
Dclk1 |
doublecortin-like kinase 1 |
39 |
0.97 |
chr3_145681452_145681628 | 4.40 |
Gm17501 |
predicted gene, 17501 |
29446 |
0.15 |
chr2_156666341_156666675 | 4.40 |
Gm14172 |
predicted gene 14172 |
33040 |
0.1 |
chr13_71148567_71148718 | 4.39 |
Mir466f-4 |
microRNA 466f-4 |
41553 |
0.19 |
chr8_92460573_92460724 | 4.39 |
Gm45336 |
predicted gene 45336 |
5119 |
0.28 |
chr14_20796775_20796968 | 4.39 |
Gm30108 |
predicted gene, 30108 |
2632 |
0.18 |
chr11_71758404_71758886 | 4.38 |
Wscd1 |
WSC domain containing 1 |
7269 |
0.18 |
chr7_68907139_68907290 | 4.37 |
Gm34664 |
predicted gene, 34664 |
7384 |
0.25 |
chr1_42889467_42889639 | 4.37 |
Mrps9 |
mitochondrial ribosomal protein S9 |
1816 |
0.36 |
chr7_48778155_48778451 | 4.36 |
Zdhhc13 |
zinc finger, DHHC domain containing 13 |
10700 |
0.16 |
chr6_25437965_25438240 | 4.35 |
Gm22529 |
predicted gene, 22529 |
238051 |
0.02 |
chr17_9580072_9580515 | 4.33 |
Gm49807 |
predicted gene, 49807 |
30602 |
0.2 |
chr7_99304833_99305309 | 4.33 |
Gm45591 |
predicted gene 45591 |
16129 |
0.12 |
chr1_42711599_42711750 | 4.32 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
1780 |
0.28 |
chr15_44706767_44707004 | 4.32 |
Sybu |
syntabulin (syntaxin-interacting) |
40903 |
0.15 |
chr11_68400068_68400578 | 4.32 |
Ntn1 |
netrin 1 |
500 |
0.82 |
chr2_91327817_91328355 | 4.31 |
Gm13787 |
predicted gene 13787 |
16103 |
0.14 |
chr1_43005870_43006021 | 4.30 |
Gpr45 |
G protein-coupled receptor 45 |
26115 |
0.14 |
chr19_59866689_59867059 | 4.27 |
Gm17203 |
predicted gene 17203 |
34188 |
0.18 |
chr12_108333504_108334768 | 4.27 |
Cyp46a1 |
cytochrome P450, family 46, subfamily a, polypeptide 1 |
245 |
0.91 |
chr3_38663983_38664148 | 4.26 |
Gm43538 |
predicted gene 43538 |
49818 |
0.15 |
chr12_5188850_5189154 | 4.26 |
Gm48532 |
predicted gene, 48532 |
46962 |
0.16 |
chr7_60492144_60492295 | 4.25 |
Gm3198 |
predicted gene 3198 |
151672 |
0.03 |
chr16_3234089_3234370 | 4.25 |
Gm23215 |
predicted gene, 23215 |
15355 |
0.17 |
chr1_176099027_176099243 | 4.25 |
Gm38081 |
predicted gene, 38081 |
66412 |
0.1 |
chr9_27299289_27299930 | 4.25 |
Igsf9b |
immunoglobulin superfamily, member 9B |
381 |
0.86 |
chr9_34488392_34488600 | 4.21 |
Kirrel3 |
kirre like nephrin family adhesion molecule 3 |
237 |
0.94 |
chr15_32569322_32569474 | 4.21 |
Sema5a |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
32277 |
0.21 |
chr15_91372669_91372820 | 4.20 |
Slc2a13 |
solute carrier family 2 (facilitated glucose transporter), member 13 |
39473 |
0.19 |
chr10_60893842_60894032 | 4.19 |
Mir6408 |
microRNA 6408 |
29086 |
0.13 |
chr16_78156629_78156811 | 4.17 |
Gm5675 |
predicted gene 5675 |
39620 |
0.15 |
chrX_7610162_7610425 | 4.17 |
Cacna1f |
calcium channel, voltage-dependent, alpha 1F subunit |
3149 |
0.1 |
chr10_71426856_71427027 | 4.17 |
Ipmk |
inositol polyphosphate multikinase |
17578 |
0.16 |
chr7_45460493_45461322 | 4.16 |
Ftl1 |
ferritin light polypeptide 1 |
1023 |
0.19 |
chr6_8956269_8957017 | 4.15 |
Nxph1 |
neurexophilin 1 |
6967 |
0.32 |
chr6_111372939_111373553 | 4.15 |
Grm7 |
glutamate receptor, metabotropic 7 |
122469 |
0.06 |
chr9_99744585_99744739 | 4.15 |
Gm23949 |
predicted gene, 23949 |
5855 |
0.19 |
chr3_132865650_132865954 | 4.15 |
Gm29811 |
predicted gene, 29811 |
12794 |
0.15 |
chr2_162282305_162282495 | 4.14 |
Ptprtos |
protein tyrosine phosphatase, receptor type T, opposite strand |
108413 |
0.07 |
chr5_72647648_72648602 | 4.13 |
Nipal1 |
NIPA-like domain containing 1 |
283 |
0.84 |
chr18_39354026_39354313 | 4.12 |
Arhgap26 |
Rho GTPase activating protein 26 |
8414 |
0.19 |
chr3_88208529_88208713 | 4.11 |
Gm3764 |
predicted gene 3764 |
851 |
0.35 |
chr4_62613321_62613879 | 4.11 |
Rgs3 |
regulator of G-protein signaling 3 |
5920 |
0.18 |
chr10_73826513_73826664 | 4.11 |
Pcdh15 |
protocadherin 15 |
4645 |
0.35 |
chr4_111517521_111517672 | 4.10 |
Agbl4 |
ATP/GTP binding protein-like 4 |
49099 |
0.15 |
chr12_81226698_81226849 | 4.10 |
Gm3693 |
predicted gene 3693 |
1511 |
0.43 |
chr5_100113364_100113515 | 4.10 |
Tmem150c |
transmembrane protein 150C |
9357 |
0.16 |
chr1_125351787_125351972 | 4.09 |
Actr3 |
ARP3 actin-related protein 3 |
45733 |
0.18 |
chr4_84202280_84202434 | 4.09 |
Gm12414 |
predicted gene 12414 |
72068 |
0.11 |
chr13_110127712_110127934 | 4.08 |
Rab3c |
RAB3C, member RAS oncogene family |
152327 |
0.04 |
chr6_58933581_58933791 | 4.08 |
Herc3 |
hect domain and RLD 3 |
26424 |
0.12 |
chr12_5410466_5410680 | 4.07 |
2810032G03Rik |
RIKEN cDNA 2810032G03 gene |
1068 |
0.61 |
chr6_52119364_52119515 | 4.07 |
Rps8-ps3 |
ribosomal protein S8, pseudogene 3 |
1197 |
0.26 |
chr4_64259899_64260093 | 4.07 |
Gm11217 |
predicted gene 11217 |
16607 |
0.27 |
chr15_24053295_24053446 | 4.07 |
Gm48918 |
predicted gene, 48918 |
45837 |
0.17 |
chr4_110290834_110291014 | 4.07 |
Elavl4 |
ELAV like RNA binding protein 4 |
31 |
0.99 |
chr4_102421225_102421376 | 4.07 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
218 |
0.97 |
chr6_54508521_54508776 | 4.06 |
Scrn1 |
secernin 1 |
713 |
0.65 |
chr4_22972841_22973202 | 4.05 |
1700025O08Rik |
RIKEN cDNA 1700025O08 gene |
34586 |
0.23 |
chr2_145958622_145958821 | 4.04 |
Crnkl1 |
crooked neck pre-mRNA splicing factor 1 |
23707 |
0.16 |
chr14_105676531_105676705 | 4.04 |
Gm10076 |
predicted gene 10076 |
5210 |
0.22 |
chrX_162087416_162087768 | 4.04 |
Gm26317 |
predicted gene, 26317 |
18135 |
0.2 |
chr12_105974243_105974455 | 4.03 |
Vrk1 |
vaccinia related kinase 1 |
35879 |
0.16 |
chr3_127705467_127706232 | 4.02 |
1500005C15Rik |
RIKEN cDNA 1500005C15 gene |
11178 |
0.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 11.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
2.3 | 6.8 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
2.2 | 6.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.9 | 7.7 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.8 | 7.3 | GO:0030035 | microspike assembly(GO:0030035) |
1.8 | 5.4 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.8 | 3.6 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.7 | 6.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.6 | 4.8 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
1.5 | 4.6 | GO:0033058 | directional locomotion(GO:0033058) |
1.4 | 5.5 | GO:0046655 | folic acid metabolic process(GO:0046655) |
1.3 | 2.5 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.2 | 4.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
1.2 | 6.9 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.1 | 3.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.1 | 3.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.1 | 1.1 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
1.1 | 3.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.0 | 4.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.0 | 8.3 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
1.0 | 3.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.9 | 3.8 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.9 | 2.7 | GO:0035106 | operant conditioning(GO:0035106) |
0.9 | 10.6 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.9 | 4.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.9 | 5.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.8 | 2.4 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.8 | 2.4 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.8 | 2.4 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.8 | 3.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.8 | 5.4 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.8 | 4.6 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.8 | 2.3 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.7 | 2.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.7 | 2.2 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.7 | 2.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.7 | 4.9 | GO:0097264 | self proteolysis(GO:0097264) |
0.7 | 2.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.7 | 1.3 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.7 | 1.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.7 | 6.0 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.7 | 2.0 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.7 | 2.6 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.6 | 1.3 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.6 | 3.0 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.6 | 3.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.6 | 4.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.6 | 1.2 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.6 | 0.6 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
0.6 | 1.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 1.1 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.6 | 2.3 | GO:0021764 | amygdala development(GO:0021764) |
0.6 | 2.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.5 | 3.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.5 | 1.6 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.5 | 1.6 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.5 | 2.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 1.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.5 | 1.6 | GO:0021586 | pons maturation(GO:0021586) |
0.5 | 1.6 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.5 | 1.5 | GO:0030421 | defecation(GO:0030421) |
0.5 | 0.5 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.5 | 1.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.5 | 2.5 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.5 | 0.5 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.5 | 1.4 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.5 | 1.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.5 | 0.9 | GO:0021564 | vagus nerve development(GO:0021564) |
0.5 | 2.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.5 | 1.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.5 | 0.9 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.5 | 1.8 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.5 | 2.3 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.5 | 1.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.5 | 1.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.4 | 2.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 1.3 | GO:0060618 | nipple development(GO:0060618) |
0.4 | 1.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.4 | 1.7 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.4 | 1.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 4.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.4 | 1.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.4 | 2.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.4 | 2.5 | GO:0031033 | myosin filament organization(GO:0031033) |
0.4 | 1.3 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.4 | 1.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 1.2 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.4 | 1.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.4 | 1.6 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.4 | 0.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.4 | 1.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 1.6 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.4 | 5.9 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.4 | 1.2 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.4 | 1.6 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.4 | 1.2 | GO:0030070 | insulin processing(GO:0030070) |
0.4 | 2.7 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.4 | 1.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.4 | 0.7 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.4 | 1.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.4 | 0.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.4 | 0.7 | GO:0001757 | somite specification(GO:0001757) |
0.4 | 1.8 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.4 | 4.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 1.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.4 | 1.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.4 | 1.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.4 | 1.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.3 | 3.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 0.7 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.3 | 1.4 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.3 | 0.3 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.3 | 1.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 1.4 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
0.3 | 1.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 6.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 1.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 1.3 | GO:0071866 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.3 | 2.6 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 1.0 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.3 | 3.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 1.3 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.3 | 1.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.3 | 1.3 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.3 | 0.9 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.3 | 0.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.3 | 0.6 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.3 | 3.0 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.3 | 2.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 1.2 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.3 | 1.8 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.3 | 0.6 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.3 | 1.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.3 | 1.5 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.3 | 0.3 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) |
0.3 | 0.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 2.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.3 | 1.7 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 2.8 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.3 | 2.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 1.4 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.3 | 1.7 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.3 | 0.5 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 1.1 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.3 | 0.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.3 | 1.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.3 | 0.5 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.3 | 0.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.3 | 0.5 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.3 | 0.8 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.3 | 0.8 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.3 | 1.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 0.5 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.3 | 2.9 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.3 | 1.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 1.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.3 | 2.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 0.8 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 0.8 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 0.3 | GO:0098868 | bone growth(GO:0098868) |
0.2 | 0.7 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 3.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.2 | 0.7 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.2 | 0.2 | GO:0002118 | aggressive behavior(GO:0002118) |
0.2 | 0.5 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 1.9 | GO:0071625 | vocalization behavior(GO:0071625) |
0.2 | 1.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 1.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.5 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 0.9 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.7 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 4.5 | GO:0001964 | startle response(GO:0001964) |
0.2 | 3.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 1.1 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.2 | 0.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 1.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 0.6 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.2 | 1.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 0.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.6 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 1.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 1.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.2 | 0.8 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.2 | 2.6 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 1.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.6 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.2 | 0.6 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.2 | 0.6 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.2 | 0.4 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.2 | 0.6 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 0.4 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.2 | 1.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.6 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 0.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 0.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.4 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.2 | 0.6 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.2 | 0.8 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.6 | GO:0097503 | sialylation(GO:0097503) |
0.2 | 1.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 1.3 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.2 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 6.0 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 0.9 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 0.4 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.2 | 0.5 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.2 | 1.6 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 1.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 0.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 0.5 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.2 | 0.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.2 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.2 | 0.9 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.2 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.2 | 0.7 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 0.9 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.2 | 0.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.5 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 0.3 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 0.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.2 | GO:0048143 | astrocyte activation(GO:0048143) |
0.2 | 0.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 0.2 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.2 | 2.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.7 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 0.2 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.2 | 0.8 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 3.4 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.2 | 0.2 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.2 | 0.5 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.2 | 0.3 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.2 | 0.5 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 0.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 1.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 1.1 | GO:0071281 | cellular response to iron ion(GO:0071281) |
0.2 | 0.6 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.2 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.2 | 0.3 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.2 | 0.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 0.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 2.4 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 0.9 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.3 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.1 | 0.4 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.7 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 1.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 1.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.7 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.1 | 0.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 1.0 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.6 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.6 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.1 | 1.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.8 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.1 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.1 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.4 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.1 | GO:0048793 | pronephros development(GO:0048793) |
0.1 | 0.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 4.0 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.4 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.3 | GO:1901656 | glycoside transport(GO:1901656) |
0.1 | 0.7 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 0.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 1.8 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 0.5 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 0.1 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 1.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 7.3 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.1 | 0.5 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.3 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.4 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.1 | 0.4 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.6 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.5 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.1 | 0.4 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.6 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 1.7 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 4.4 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 1.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 1.0 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.2 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.1 | 0.2 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) |
0.1 | 1.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.4 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.6 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.1 | 0.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 1.9 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 1.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 1.1 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 1.5 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 1.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 3.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.2 | GO:0007418 | ventral midline development(GO:0007418) |
0.1 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.4 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.1 | 0.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.1 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.1 | 0.2 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.1 | 0.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.5 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 4.0 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.1 | 0.2 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.1 | 0.4 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.3 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.5 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 1.8 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.1 | 1.9 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 3.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.1 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.1 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.3 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.2 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) regulation of collateral sprouting in absence of injury(GO:0048696) |
0.1 | 0.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.9 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.4 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 1.1 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.2 | GO:0072077 | renal vesicle morphogenesis(GO:0072077) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.3 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.1 | GO:0061439 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.1 | 0.3 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.2 | GO:0019230 | proprioception(GO:0019230) |
0.1 | 0.3 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.1 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) |
0.1 | 0.9 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.1 | 0.7 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.9 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.6 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.2 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.6 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.1 | 0.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.2 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.2 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.7 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.2 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.2 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 1.4 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.5 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.2 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 | 1.7 | GO:0007588 | excretion(GO:0007588) |
0.1 | 3.7 | GO:0001764 | neuron migration(GO:0001764) |
0.1 | 0.2 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.3 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 4.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.4 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.6 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.3 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.3 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.1 | 0.6 | GO:0097369 | sodium ion import(GO:0097369) |
0.1 | 2.0 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.1 | 0.1 | GO:0090427 | activation of meiosis(GO:0090427) |
0.1 | 0.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 0.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.1 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.7 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.1 | 0.2 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.3 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.1 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.3 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.1 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.6 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.1 | 0.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.1 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.1 | 0.3 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.1 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.1 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.1 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.5 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.5 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.2 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.3 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.5 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.1 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.1 | 0.2 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.1 | 0.3 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.6 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.1 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 1.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.2 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.1 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.1 | 0.2 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 1.0 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.1 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.1 | 0.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.1 | 0.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.2 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.5 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.3 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 1.0 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.1 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.1 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.1 | 0.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 1.2 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.3 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.2 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.3 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.9 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.2 | GO:0001975 | response to amphetamine(GO:0001975) |
0.0 | 0.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 0.1 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.1 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.0 | 0.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.2 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.5 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.0 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.0 | 0.0 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.0 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 0.3 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.0 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.1 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.0 | 0.2 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.0 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.2 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
0.0 | 0.1 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.1 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.0 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.2 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 1.0 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.2 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.0 | 0.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.0 | 0.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.0 | 0.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.1 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.0 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.1 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.1 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.1 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.1 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.2 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.0 | 0.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.0 | GO:0098815 | modulation of excitatory postsynaptic potential(GO:0098815) |
0.0 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.6 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.0 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.0 | 0.0 | GO:0035482 | gastric motility(GO:0035482) |
0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.0 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.0 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.1 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.2 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.2 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.1 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.0 | 0.2 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.1 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.0 | 0.0 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.0 | 0.0 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.0 | 0.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.0 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.5 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.0 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.0 | 0.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.2 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.0 | 0.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.0 | 0.1 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.0 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
0.0 | 0.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.1 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.0 | 0.1 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.0 | 0.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.0 | 0.0 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.0 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.0 | 0.0 | GO:0070091 | glucagon secretion(GO:0070091) |
0.0 | 0.0 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.0 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.1 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.0 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.0 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.0 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.0 | 0.0 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
0.0 | 0.0 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.0 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.0 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.0 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.1 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 0.0 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.0 | 0.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.0 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 0.1 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.0 | 0.0 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.0 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.1 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.0 | 0.2 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.0 | 0.0 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.0 | 0.0 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.0 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.0 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.2 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.1 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.0 | 0.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.0 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.1 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.0 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.0 | 0.0 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.1 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.0 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.0 | 0.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.0 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) |
0.0 | 0.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.0 | 0.0 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.1 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.0 | 0.1 | GO:0009130 | UMP biosynthetic process(GO:0006222) pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.1 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.0 | 0.0 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.0 | 0.1 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.0 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.0 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.0 | 0.0 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.0 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.0 | 0.0 | GO:0015867 | ATP transport(GO:0015867) |
0.0 | 0.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.0 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.9 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.0 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
0.0 | 0.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.0 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.0 | 0.0 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.0 | 0.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.0 | 0.0 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.0 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.0 | 0.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 0.1 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 0.2 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.2 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.2 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.0 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 7.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.3 | 5.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.1 | 8.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.9 | 2.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.7 | 4.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.7 | 3.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.7 | 3.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.7 | 3.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.6 | 1.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.6 | 1.7 | GO:1990635 | proximal dendrite(GO:1990635) |
0.6 | 5.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.6 | 2.2 | GO:0042825 | TAP complex(GO:0042825) |
0.5 | 6.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.5 | 1.4 | GO:0044393 | microspike(GO:0044393) |
0.4 | 7.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.4 | 8.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 1.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 6.2 | GO:0031045 | dense core granule(GO:0031045) |
0.4 | 1.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 5.6 | GO:0033268 | node of Ranvier(GO:0033268) |
0.4 | 2.4 | GO:0045180 | basal cortex(GO:0045180) |
0.4 | 1.2 | GO:0055087 | Ski complex(GO:0055087) |
0.4 | 2.2 | GO:0097449 | astrocyte projection(GO:0097449) |
0.4 | 0.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 1.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 2.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 3.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 1.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 0.9 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.3 | 1.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 0.9 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 4.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 1.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 4.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 0.8 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.3 | 16.1 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 4.8 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 1.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 1.5 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 1.5 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 0.7 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 1.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.2 | 1.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 0.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 2.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 3.3 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.2 | 1.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 2.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 2.4 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 3.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 2.8 | GO:0031430 | M band(GO:0031430) |
0.2 | 1.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.6 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 1.7 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 0.7 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 1.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 0.9 | GO:0097433 | dense body(GO:0097433) |
0.2 | 0.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 0.9 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 1.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 0.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 2.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 0.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.4 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.6 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 1.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 1.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 1.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 7.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 1.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.9 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 3.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.9 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 6.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.7 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.5 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 3.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 1.6 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 7.9 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.4 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 3.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
0.1 | 1.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 18.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 1.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 5.1 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 6.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.1 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.4 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.0 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.1 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.0 | 2.3 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 1.9 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 3.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.4 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 18.4 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.2 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.2 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.0 | 0.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.2 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 0.2 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.0 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.3 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.0 | GO:0000235 | astral microtubule(GO:0000235) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 11.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.7 | 10.3 | GO:0048495 | Roundabout binding(GO:0048495) |
1.6 | 8.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.4 | 7.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.4 | 4.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.2 | 6.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.0 | 5.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.9 | 2.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.9 | 2.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.9 | 2.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.8 | 2.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.8 | 3.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.8 | 6.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.8 | 2.3 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.8 | 2.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.7 | 6.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.7 | 3.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.7 | 3.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.7 | 4.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 1.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.6 | 2.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.6 | 1.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.6 | 2.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.6 | 2.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.6 | 2.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.5 | 1.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.5 | 2.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 1.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.5 | 1.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.4 | 1.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.4 | 4.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.4 | 3.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 4.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.4 | 4.8 | GO:0019841 | retinol binding(GO:0019841) |
0.4 | 2.4 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.4 | 1.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 1.5 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.4 | 1.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.4 | 5.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.4 | 2.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 6.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.3 | 2.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 1.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.3 | 1.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 5.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 0.7 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.3 | 2.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 1.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 0.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 0.9 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.3 | 7.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 1.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 1.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 1.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.3 | 1.4 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.3 | 2.3 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.3 | 5.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 7.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 3.4 | GO:0031404 | chloride ion binding(GO:0031404) |
0.3 | 1.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 3.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 1.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.3 | 1.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 1.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 0.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 4.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 2.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 2.2 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 0.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 0.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 2.7 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.2 | 0.7 | GO:0034559 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.2 | 3.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 1.3 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.2 | 1.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.2 | 1.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 1.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 5.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 1.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 6.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 1.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 3.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 3.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 1.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 0.9 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 1.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.9 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.2 | 1.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 0.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 1.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 1.8 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.2 | 0.3 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 0.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 1.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 0.6 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 0.6 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 0.9 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 1.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.2 | 1.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 1.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 6.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 1.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 1.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 1.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 1.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.8 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 1.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 5.3 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.7 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.1 | 1.0 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 1.6 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 1.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 2.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 1.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.8 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 7.0 | GO:0042562 | hormone binding(GO:0042562) |
0.1 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.3 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 2.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.7 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 1.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.6 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 1.0 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.1 | 1.3 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.6 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.1 | 0.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 1.0 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 1.0 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 1.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 3.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.3 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 1.8 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 1.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 1.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.9 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.3 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.1 | 0.1 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.1 | 0.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.4 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 0.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 1.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.7 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 1.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 4.9 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 1.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 1.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.2 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.4 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 0.3 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.5 | GO:0018855 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.2 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.3 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.7 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 1.9 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.8 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 1.0 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.0 | 0.3 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.7 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.0 | 0.9 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.0 | 2.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.9 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.0 | 0.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.7 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.0 | 0.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.0 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.0 | 0.0 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.7 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.0 | 0.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.0 | 0.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.0 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.0 | 0.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.0 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.0 | 0.0 | GO:0035276 | ethanol binding(GO:0035276) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.7 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.0 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.1 | GO:0045340 | mercury ion binding(GO:0045340) |
0.0 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.0 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.0 | 0.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 11.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.4 | 5.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 13.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 6.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 6.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 0.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 4.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 2.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 3.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 3.7 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 4.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 1.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 2.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 2.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 3.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 2.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 15.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 3.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 1.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.9 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 1.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 8.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.7 | 7.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.6 | 22.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.6 | 7.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.5 | 1.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.5 | 5.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.4 | 4.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 2.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.4 | 5.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 4.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 4.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 5.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 1.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.3 | 5.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 3.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 0.5 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.2 | 2.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 2.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 7.7 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.2 | 0.8 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.2 | 1.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 1.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 0.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 2.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 5.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 3.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 1.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 2.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.5 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 1.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 3.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 2.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 4.8 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 3.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 1.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 2.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 2.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.8 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 1.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 0.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 1.0 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.0 | 0.1 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.2 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 1.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.1 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.0 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.3 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 1.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 1.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |